Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.
Investigations sponsored by the ISS National Laboratory will be performed, including tissue chip investigations to study liver regeneration and the immune aging process.
The company will use the funds to expand its value-based cancer care network and extend its reach with health plans, employers and providers.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
The partners created a registry to generate real-world data using consenting U.S. patients' medical records to further research in stage 1 to 3 breast cancer.
The company's portable, battery-operated and Bluetooth-connected device with RPM capabilities enables patients to complete respiratory treatments from anywhere.
They are also considering developing a senior care service leveraging AI.
The life sciences company's Gut Intelligence Test will be available in 200 CVS locations and through the drugstore chain online.
Ravideep Singh discusses why architects must design hospitals with sustainable infrastructure in mind to improve the effectiveness and efficiency of healthcare systems and the patient experience.
Also, a new predictive algorithm can predict the survival of a patient on ECMO.
